M12 — M1 Kliniken AG Income Statement
0.000.00%
- €306.78m
- €332.38m
- €316.32m
- 95
- 49
- 54
- 78
Annual income statement for M1 Kliniken AG, fiscal year end - December 31st, EUR millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 77.2 | 160 | 315 | 285 | 316 |
Cost of Revenue | |||||
Gross Profit | 31.6 | 36.8 | 55.3 | 52.8 | 50.2 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 69.3 | 155 | 302 | 276 | 301 |
Operating Profit | 7.95 | 4.41 | 12.1 | 9.35 | 15.7 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 12.8 | 8.78 | 14.4 | 10.2 | 16.4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 9.73 | 7.42 | 10.9 | 7.07 | 11.7 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | 9.73 | 6.82 | 8.91 | 4.32 | 10.3 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 9.73 | 6.82 | 8.91 | 4.32 | 10.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.556 | 0.366 | 0.453 | 0.219 | 0.488 |
Dividends per Share |